StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Aspira Women's Health's enterprise value was $11.67M on Oct 19, 2026, against $18.10M a year earlier. Over the last 5 years it ranged from $1.40M to $191.27M, with a median of $23.29M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$11.67M-52.2%
2025Dec 31, 2025$24.40M+122.0%
2024Dec 31, 2024$10.99M-71.5%
2023Dec 29, 2023$38.54M+65.5%
2022Dec 30, 2022$23.29M-85.1%
2021Dec 31, 2021$156.52M-77.0%
2020Dec 31, 2020$681.44M+940.9%
2019Dec 31, 2019$65.47M+428.7%
2018Dec 31, 2018$12.38M-88.7%
2017Dec 29, 2017$109.76M+152.6%
2016Dec 30, 2016$43.46M-37.6%
2015Dec 31, 2015$69.64M+24.6%
2014Dec 31, 2014$55.91M+33.3%
2013Dec 31, 2013$41.93M+305.5%
2012Dec 31, 2012$10.34M–
2011Dec 30, 2011-$9.86M–

More Aspira Women's Health figures

See a number that looks wrong?